<DOC>
<DOCNO>EP-0651649</DOCNO> 
<TEXT>
<INVENTION-TITLE>
GRANULOCYTE COLONY-STIMULATING FACTOR SOLUTION DELIVERY METHOD
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3819	A61M3700	A61K922	A61K3800	A61K3800	A61K900	A61K922	A61P3100	A61M3700	A61P3104	A61K3819	A61K900	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61M	A61K	A61K	A61K	A61K	A61K	A61P	A61M	A61P	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61M37	A61K9	A61K38	A61K38	A61K9	A61K9	A61P31	A61M37	A61P31	A61K38	A61K9	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
RHONE POULENC RORER SA
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE-POULENC RORER S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BOUSSEAU ANNE
</INVENTOR-NAME>
<INVENTOR-NAME>
FRYDMAN ARMAND
</INVENTOR-NAME>
<INVENTOR-NAME>
PLARD JEAN-PAUL
</INVENTOR-NAME>
<INVENTOR-NAME>
SPENLEHAUER GILLES
</INVENTOR-NAME>
<INVENTOR-NAME>
VEILLARD MICHEL
</INVENTOR-NAME>
<INVENTOR-NAME>
BOUSSEAU, ANNE
</INVENTOR-NAME>
<INVENTOR-NAME>
FRYDMAN, ARMAND
</INVENTOR-NAME>
<INVENTOR-NAME>
PLARD, JEAN-PAUL
</INVENTOR-NAME>
<INVENTOR-NAME>
SPENLEHAUER, GILLES
</INVENTOR-NAME>
<INVENTOR-NAME>
VEILLARD, MICHEL
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of granulocyte-colony stimulating factor for the 
preparation of a medicament for use in the treatment of 

risks of infectious diseases during chemotherapeutic 
treatments, characterized in that the said medicament is 

delivered continuously subcutaneously. 
</CLAIMS>
</TEXT>
</DOC>
